Click for St. Louis, Missouri Forecast

// a href = ./ // St Louis News, Weather, Sports, The Big 550 AM, St Louis Traffic, Breaking News in St Louis

 
 
 

COURT: CAN HUMAN GENES BE PATENTED?

Rate this item
(0 votes)
COURT: CAN HUMAN GENES BE PATENTED? AP
WASHINGTON (AP) -- DNA may be the building block of life, but can something taken from it also be the building block of a multimillion-dollar medical monopoly?

The Supreme Court grapples Monday with the question of whether human genes can be patented. Its ultimate answer could reshape U.S. medical research, the fight against diseases like breast and ovarian cancer and the multi-billion dollar medical and biotechnology business.

"The intellectual framework that comes out of the decision could have a significant impact on other patents - for antibiotics, vaccines, hormones, stem cells and diagnostics on infectious microbes that are found in nature," Robert Cook-Deegan, director for genome ethics, law & policy at Duke University, said in a statement.

"This could affect agricultural biotechnology, environmental biotechnology, green-tech, the use of organisms to produce alternative fuels and other applications," he said.

The nine justices' decision will also have a profound effect on American business, with billions of dollars of investment and years of research on the line. The U.S. Patent and Trademark Office has been awarding patents on human genes for almost 30 years.

And Myriad Genetics alone has $500 million invested in the patents being argued over in this case. Without the ability to recoup that investment, breakthrough scientific discoveries needed to combat all kind of medical maladies wouldn't happen, the company says.

"Countless companies and investors have risked billions of dollars to research and develop scientific advances under the promise of strong patent protection," said Peter D. Meldrum, the president and CEO of Myriad Genetics, in a statement.

But their opponents argue that allowing companies like Myriad to patent human genes or parts of human genes will slow down or cripple lifesaving medical research like in the battle against breast cancer.

"What that means is that no other researcher or doctor can develop an additional test, therapy or conduct research on these genes," said Karuna Jagger, executive director of Breast Cancer Action.

The Supreme Court has already said that abstract ideas, natural phenomena and laws of nature cannot be given a patent, which gives an inventor the right to prevent others from making, using or selling a novel device, process or application.

Myriad's case involves patents on two genes linked to increased risk of breast and ovarian cancer. Myriad's BRACAnalysis test looks for mutations on the breast cancer predisposition gene, or BRCA. Those mutations are associated with much greater risks of breast and ovarian cancer.

Women with a faulty gene have a three to seven times greater risk of developing breast cancer and a higher risk of ovarian cancer. Men can also carry a BRCA mutation, raising their risk of prostate, pancreatic and other types of cancer. The mutations are most common in people of eastern European Jewish descent.

Myriad sells the only BRCA gene test.

The American Civil Liberties Union challenged Myriad's patents, arguing that genes couldn't be patented, and in March 2010 a New York district court agreed. But the U.S. Court of Appeals for the Federal Circuit has now twice ruled that genes can be patented. In Myriad's case, it's because the isolated DNA has a "markedly different chemical structure" from DNA within the body.

Mark C. Capone, president of Myriad Genetics Laboratories, Inc., a subsidiary of Myriad, said some of the concerns over what they have patented are overblown and some simply incorrect.

"Myriad cannot, should not and has not patented genes as they exist in the human body on DNA," Capone said in an interview. "This case is truly about isolated DNA molecules which are synthetic chemicals created by the human ingenuity of man that have very important clinical utilities, which is why this was eligible for a patent."

But the ACLU is arguing that isolating the DNA molecules doesn't stop them from being DNA molecules, which they say aren't patentable.

"Under this theory, Hans Dehmelt, who won the Nobel Prize for being the first to isolate a single electron from an atom, could have patented the electron itself," said Christopher A. Hansen, the ACLU's lawyer in court papers. "A kidney removed from the body (or gold extracted from a stream) would be patentable subject matter."

The Obama administration seems to agree. Artificially created DNA can be patented, but "isolated but otherwise unmodified genomic DNA is not patent-eligible," Solicitor General Donald Verrilli said in court papers.

That was the ruling of the original judge who looked at Myriad's patents after they were challenged by the ACLU in 2009. U.S. District Judge Robert Sweet said he invalidated the patents because DNA's existence in an isolated form does not alter the fundamental quality of DNA as it exists in the body or the information it encodes. But the federal appeals court reversed him in 2011, saying Myriad's genes can be patented because the isolated DNA has a "markedly different chemical structure" from DNA within the body.

The Supreme Court threw out that decision and sent the case back to the lower courts for rehearing. This came after the high court unanimously threw out patents on a Prometheus Laboratories, Inc., test that could help doctors set drug doses for autoimmune diseases like Crohn's disease, saying the laws of nature are unpatentable.

But the federal circuit upheld Myriad's patents again in August, leading to the current review. The court will rule before the end of the summer.

"The key issue now for the court will therefore be whether the scientist working in the lab to isolate a particular gene innovated in a way that allows for that isolated gene to be patented," said Bruce Wexler, a lawyer with the law firm Paul Hastings, who advises pharmaceutical and biotech companies on patent issues.

The case is 12-398, Association for Molecular Pathology v. Myriad Genetics, Inc.

© 2013 THE ASSOCIATED PRESS. ALL RIGHTS RESERVED. THIS MATERIAL MAY NOT BE PUBLISHED, BROADCAST, REWRITTEN OR REDISTRIBUTED. Learn more about our PRIVACY POLICY and TERMS OF USE.
Last modified on Monday, 15 April 2013 08:47

Latest News

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
Prev Next
OFFICIALS ALARMED BY INCREASING SUPERBUG REPORTS

OFFICIALS ALARMED BY INCREASING SUPERBUG REPORTS

NEW YORK (AP) -- Health officials are reporting an alarming increase in some dangerous superbugs at U.S. hospitals. These superbugs from a common germ family have become extreme...

JUST 1 IN 4 YOUNG TEENS MEET US FITNESS GUIDELINES

JUST 1 IN 4 YOUNG TEENS MEET US FITNESS GUIDELINES

CHICAGO (AP) -- Young teens aren't exactly embracing the government's Let's Move mantra, the latest fitness data suggest. Only 1 in 4 U.S. kids aged 12 to 15 meet the recomm...

MARKETING EFFORTS TO UNINSURED YOUTH RAMP UP

MARKETING EFFORTS TO UNINSURED YOUTH RAMP UP

MIAMI (AP) -- The so-called "young invincibles" are so important to the success of the Affordable Care Act that supporters and detractors are spending millions to reach them wit...

WOMEN HAVE NEW OPTIONS FOR BREAST CANCER SURGERY

WOMEN HAVE NEW OPTIONS FOR BREAST CANCER SURGERY

CHICAGO (AP) -- Treating breast cancer almost always involves surgery, and for years the choice was just having the lump or the whole breast removed. Now, new approaches are dramat...

SWEDISH DOCTORS TRANSPLANT WOMBS INTO 9 WOMEN

SWEDISH DOCTORS TRANSPLANT WOMBS INTO 9 WOMEN

STOCKHOLM (AP) -- Nine women in Sweden have successfully received transplanted wombs donated from relatives in an experimental procedure that has raised some ethical concerns. T...

SOME IMMIGRANTS EXCLUDED FROM HEALTH CARE OVERHAUL

SOME IMMIGRANTS EXCLUDED FROM HEALTH CARE OVERHAUL

PHOENIX (AP) -- President Barack Obama has championed two sweeping policy changes that could transform how people live in the United States: affordable health care for all and a pa...

Study: Better TV might improve kids' behavior

Study: Better TV might improve kids' behavior

SEATTLE (AP) - A new study has found teaching parents to switch channels from violent shows to educational TV can improve preschoolers' behavior, even without getting them to watch...

CRITICS SEEK TO DELAY NYC SUGARY DRINKS SIZE LIMIT

CRITICS SEEK TO DELAY NYC SUGARY DRINKS SIZE LIMIT

NEW YORK (AP) -- Opponents are pressing to delay enforcement of the city's novel plan to crack down on supersized, sugary drinks, saying businesses shouldn't have to spend millions...

© 2013 KTRS All Rights Reserved